Invitae
In Brief This Week: German Cancer Aid, Labcorp, Neurogene, SCG Cell Therapy
News items for the week of Aug. 5, 2024.
In Brief This Week: Invitae, BioAtla, GeneCentric, AC Immune, ObvioHealth, Allarity, Anixa
News items for the week of July 22, 2024.
Breast Cancer Patients With VUS Generally Not Overtreated, Real-World Data Analysis Suggests
Premium
A study drawing on germline genetic testing and claims data showed at ASCO that patients with VUS are, for the most part, managed like they have negative results.
Invitae, BridgeBio Pharma Partner on Rare Disease Drug Discovery
The agreement combines BridgeBio's therapeutics expertise with Invitae's datasets to find new rare disease targets and therapeutics.
California Governor Signs Bill That Specifies PGx Testing is Covered Under Medi-Cal
AB 425 makes pharmacogenetic testing a covered benefit under the state healthcare coverage program for low-income residents starting July 1, 2024.
Nov 9, 2021